KCTD9 抗体 (AA 1-200)
Quick Overview for KCTD9 抗体 (AA 1-200) (ABIN7145864)
抗原
适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-200
- 
                                            交叉反应
- 人
- 
                                            纯化方法
- >95%, Protein G purified
- 
                                            免疫原
- Recombinant Human BTB/POZ domain-containing protein KCTD9 protein (1-200AA)
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Recommended dilution: WB:1:1000-1:5000,
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            缓冲液
- 
                        Preservative: 0.03 % Proclin 300
 Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
- 
                                            储存液
- ProClin
- 
                                            注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C,-80 °C
- 
                                            储存方法
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
 
- 
                                            
- 
    - KCTD9 (Potassium Channel Tetramerisation Domain Containing 9 (KCTD9))
- 
                                            别名
- KCTD9
- 
                                            背景
- 
                        Background: Substrate-specific adapter of a BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex, which mediates the ubiquitination of target proteins, leading to their degradation by the proteasome. Aliases: KCTD9 antibody, BTB/POZ domain-containing protein KCTD9 antibody 
- 
                                            UniProt
- Q7L273
 抗原
- 
                    
 
                                     
                                     
                                    